Blending Treatments Worldwide for Multiple Myeloma

David S. Siegel, MD, PhD

Video Categories: Hematological Malignancies

David S. Siegel, MD, PhD, at the John Theurer Cancer Center in Hackensack, NJ, explains the benefits of worldwide clinical trials in creating more consistent, less toxic treatment options for multiple myeloma. New drugs are coming along, and the clinical trials for those drugs are beginning to mature.

Related Videos

January 30, 2014

Oncology and the Affordable Care Act

Hear as Dr Agarwala deliberates the impact of the Affordable Care Act on oncology care.

March 31, 2015

Precision Medicine for CLL

Dr. Jennifer R. Brown deliberates on the state of personalized medicine in relation to CLL. She explains that the targeted drugs currently used for CLL actually work for most patients, rather than just a subgroup. Also, CLL therapies are now generally in pill form and well tolerated with few side [ Read More ]